Umoja Biopharma is a biotechnology company that is focused on developing novel cancer therapies. The company's platform is based on a proprietary technology that enables it to identify and target cancer cells with high precision. Umoja Biopharma's lead product candidate is currently in preclinical development, and the company is planning to initiate clinical trials in the near future. The company is headquartered in Waltham, Massachusetts.